Most medical device companies have invested in sophisticated engineering and quality systems. CAD platforms, PLM software, and QMS applications each perform their intended role exceptionally well. Therefore, why do traceability gaps continue to surface during design reviews, FDA inspections, and product development?
Because the issue usually isn’t the tools. It is the disconnect between them.
As devices become more complex, engineering decisions no longer affect a single drawing or component. A seemingly routine change can impact risk analyses, supplier qualifications, verification activities, biocompatibility, and regulatory documentation simultaneously. When those relationships aren’t visible in real time, blind spots emerge.
Why This Problem Is Getting Worse
Medical devices today combine mechanical systems, electronics, embedded software, AI, connectivity, and increasingly complex supply chains. That complexity isn’t linear. Every new requirement, component, interface or software function creates additional relationships that must remain synchronized. Double the number of components and you create far more than twice the number of interactions.
Eventually, no engineer, and certainly no spreadsheet can reliably keep track of every downstream dependency. That’s when disconnected systems begin working against one another.
Five Signs Your CAD Tool and QMS Aren’t Truly Connected
Many organizations believe their design controls are under control until these warning signs appear.
- Engineers stop engineering before every design review. If milestone reviews become documentation catch-up exercises instead of engineering discussions, traceability is being maintained periodically rather than continuously.
- Engineering changes are routinely labeled “minor.” A change may appear insignificant inside CAD, but every modification should trigger questions about risks, verification, supplier qualification, regulatory impact, and design history.
- Teams discover impacts through meetings instead of their systems. If engineering, quality, regulatory, and manufacturing must manually determine who is affected after a change occurs, your people are providing the visibility, not your systems.
- Quality identifies upstream and/or downstream impacts after engineering decisions have already been made. By then, valuable time has already been lost.
- Auditors ask questions that require searching multiple systems. If demonstrating traceability means opening several applications and spreadsheets to connect requirements, risks, verification, and design outputs, you have identified a design controls gap.
When a “Better” Design Creates a Bigger Problem
Consider a laparoscopic surgical device where engineers decide to replace a stainless-steel cutting component with titanium after a supplier improves manufacturing capability. From an engineering perspective, the decision makes sense. But the original biocompatibility testing was completed using stainless steel. Suddenly, one engineering improvement affects multiple downstream activities:
- Biocompatibility documentation
- Risk management files
- Verification planning
- Regulatory submissions
- Project schedule
Nothing failed mechanically. What failed was visibility. Without a connected system exposing those dependencies immediately, the organization may not discover the impact until months later, which results in significant cost and launch delays.
The same scenario occurs when changing coatings, tolerances, approved suppliers, or software functionality. What appears to be one engineering decision often carries consequences well beyond the CAD model.
Regulators Are Looking Between the Systems
Historically, organizations focused on producing the required documentation. Today’s regulatory expectations increasingly emphasize demonstrating connected traceability throughout development. Auditors don’t simply ask whether verification was completed. They ask:
- What requirement drove this test?
- Which risk was it intended to mitigate?
- What engineering change triggered the update?
- Why was this change considered minor?
Increasingly, regulators are not just evaluating whether individual documents exist. They are evaluating the relationships between requirements, risks, design decisions, verification, and change management. Disconnected systems make those answers difficult to produce, while connected systems make them visible throughout development.
Design for Continuous Traceability
The goal is not to replace engineers, their engineering judgment or ability to make technical decisions. The objective is to give engineers immediate visibility into every downstream impact before implementation begins.
Connected design environments allow organizations to identify affected requirements, risks, suppliers, verification activities, and documentation the moment a change occurs. That enables engineering, quality, and regulatory teams to collaborate while decisions are still being made and not weeks or months later.
As products become increasingly software-driven, AI-enabled, and interconnected, maintaining traceability through disconnected tools and manual processes becomes progressively more difficult.
The organizations that succeed won’t necessarily have more documentation. They will have better visibility. And in today’s regulatory environment, visibility has become one of the most valuable engineering tools of all.
